The study, led by Patrick Singleton, PhD, adds evidence that mu opioid receptors in cancer cells influence cancer progression and spread. These receptors could become a therapeutic target for cancer treatment.
Dr. Singleton’s findings also could influence surgical anesthesia used during cancer surgery.
More Articles on Anesthesia:
Anesthesia Machine Sales Expected to Increase by 2014
Dr. Brett Anderson Named Heritage Valley Chair of Anesthesiology
FDA Does Not Approve Zogenix’s Zohydro Opioid Pain Medication
